Summary.-In mice given a single dose of diethylnitrosamine, a hepatonecrotic dose of carbon tetrachloride, 5 weeks after dosing with DEN and repeated 6 times at 4-weekly intervals, augmented the tumour yield in the livers. A single hepatonecrotic dose of CC14 24 h before a single dose of DEN also increased the number of tumours produced. The effect of the repeated administration of CC14 after the dose of DEN occurred in addition to, and was therefore independent of, the enhancing effect of a single dose of CC14 before DEN.
THlE number of tumours produced in the liver of animals given a dose of diethylnitrosamine (DEN) is increased if they are previously subjected to partial hepatectomy (Griinthal et al., 1970) or treated with a hepatonecrotic dose of CC14 (Pound, 1978) . The variation of the tumour yield with the interval between the two treatments has led to the opinion that the liver is more susceptible to the carcinogenic action when the cells are proliferating rapidly in the regenerative phase, although a particular susceptible phase of the cell cycle has not been demonstrated. Factors affecting the metabolic activation of the carcinogens complicate the issue (Pound and Lawson, 1975) . A similar susceptibility of proliferating tissue is shared by other nitrosamines (Craddock, 1975; Pound, 1978) and other carcinogens. Since tumours do not appear until some time after giving the carcinogen, that persists in the tissues only for a short time after a single injection, the interpretations have been advanced that (1) a proportion of the cells of the liver is altered in some way such that they may develop into tumours, and (2) this proportion is increased when the carcinogen is given to a proliferating tissue. The question therefore arises whether conditions exist that stimulate such latent cells to develop into tumours either more rapidly or in greater number, such as are provided by the promoting agent croton oil in the classical two-stage mechanism developed as a hypothesis primarily to elucidate carcinogenesis in the mouse skin.
Marginal increases in the yields of hepatocellular tumours due to ionizing irradiation have been reported by the action of a hepatonecrotic dose of CC14 up to 9 months later (Cole and Nowell, 1965; Curtis, Czernik and Tilley, 1968) and by partial hepatectomy after a dose of Xirradiation (Haran-Ghera et al., 1962) . Similar results have been found in rats subjected to 3 partial hepatectomies at 5-week intervals starting 5 weeks after a dose of DEN a relatively poor liver carcinogen in this animal-and grounds discussed for regarding even a marginal increase under these conditions as significant (Pound and McGuire, 1978 Six identically treated groups of inice were randomly constituted at the same time and used to provide specimens of livers after 20 weeks (i.e. just before the 4th injection of CC14 was due) and after 35 weeks (i.e. just before the 7th injection of CC14 was due), at which times 5 animals of each of these groups -were killed and the livers removed for examination.
Livers were examined by cutting into thin slices. The numbers of tumours and "wvhite spots" (focal proliferations presenting on the surface (see below)) was counted. The mean diameter of tumours was measured. The number of cystic lesions (cholangiomata) and the size of these lesions was also determined.
Sections of the livers were systematically scanned for the presence of focal proliferations, and the number recorded as the number per cm2 of section (Pound, 1978) . Sections of the livers from the 20-and 35-week specimens were similarly scanned but (for technical reasons) only areas of 0 5 cm2 were examined, so the figures are not comparable with those of the autopsy specimens.
RESULTS
The animals of all groups remained in reasonable condition, although those treated with DEN appeared to be smaller than those in the control CCl4-treated groups. Animal weights at autopsy varied considerably within the groups, so that the apparent difference in size was not statistically significant, and, in any event, is of no value since in some animals tumours were up to 3 cm or more in diameter. Livers appeared to be about normal size when the presence of tumours did not interfere with assessment. The death rates in DEN-treated mice and especially in the DEN-multiple CC14-treated groups were somewhat greater than in the other groups, but the differences were not significantly different; the dead animals in later stages had a high incidence of large and multiple tumours of the liver in the former groups.
Histological examination of the liver (apart from proliferative lesions of the hepatocytes and bile ducts) showed no relevant structural abnormality at any .f5 Q stage. In particular, there was no evidence of fibrosis or cirrhosis. The doses of CC14 used (0-25 ml/kg) would produce necrosis of between 40 and 7000 of the liver in the centrilobular zones so that after 7 doses a considerable degree of hyperplasia must have occurred. The livers from animals sampled at 20 and 35 weeks showed some degree of accumulation of glycogen in the hepatocytes, indicating some functional disturbance under these treatments. No tumours were found in the livers or kidneys of the animals of Group 5 given multiple injections of CC14, nor in the animals of Group 6 given a single injection. Secondary embolic tumours were seen in one kidney, but resembled the pulmonary "adenomas" in the animal rather than any area of the large hepatocellular tumours present in the same animal. The number of tumours and other lesions in the liver and kidneys of the mice surviving 52 weeks is set out in Table I . Occasional tuLmours in the lungs and other sites are not considered. The relevant lesions in the liver comprised hepatocellular tumours, focal proliferations, lesions termed "white spots", and cystic lesions of bile-duct origin. Kidney tumours A small number of tumours was seen in the kidneys at necropsy. These were papillary adenomas or adenocarcinomas of a type described elsewhere (Pound et al., 1973; Pound, 1978) . The number of these lesions in mice given CC14 before DEN was greater than in mice given DEN without prior treatment, not significantly so (X2 1-5, 1 d.f., 0-1>P>0 05), but consistent with previous findings in rats (Pound et al., 1.973 ) and mice (Pound, 1978) . On the other hand, injections of CC14 after DEN had no influence on the yield of the kidney tumours. In addition, the kidneys showed a number of "papillary cysts" (Pound et al., 1973; Pound, 1978; McGiven and Ireton, 1972) . These lesions are not considered further.
Hepatocellular lesions
The lesions classified as hepatocellular tumours and focal proliferations have been described briefly in the rat (Pound et al., 1973; Pound and McGuire, 1978) and in the mouse (Pound, 1978) . They fall into 3 types according to the cells comprising them; clear cell, liver cell and dark cell. In the rat the clear-cell type is the most frequent and the dark-cell type the least, whereas in the mouse the livercell and dark-cell types are the most frequent. Focal proliferations in the mouse invade veins (Pound, 1978) 
Cholangiomas
These lesions consisted of multilocular cysts, sometimes with few, at other times with many loculi containing thin fluid and lined by cuboidal epithelium resembling that of the bile ducts. They varied in size from -'3 mm to 35 mm diameter. They were seen only in animals 35 weeks or more after the dose of DEN, and therefore appear to develop at a slower rate than hepatocellular tumours. They were frequently accompanied by small foci of bileduct proliferation, as has been noted in rats given dimethylnitrosamine (Pound et al., 1973) . Having once appeared they seem to enlarge and grow progressively, and hence are regarded as neoplastic. They are referred to as cholangiomas or cholangiomatous cysts.
Distribution of liver tumours
The proportion of animals with hepatocellular tumours (Table I) The number of "white spots" also varies significantly between groups (Table II) . Histologically, "white spots" are focal proliferations that appear on the surface and provide an index of the incidence of the lesions as indicated by comparing the counts of "white spots" with the estimates of the numbers of focal proliferations obtained by scanning sections (Table III) (Table III) of the lesions in Groups 1 and 2 perhaps suggests that the lesions grow more rapidly in these groups, which would make them more readily observed, as well as suggesting that they have been present for a longer time (i.e. appeared earlier).
The number of focal proliferations in the groups varies with the number of tumours, as found previously in rats (Pound et al., 1973) and mice (Pound, 1978) .
Distribution of cholangiomatous cysts
The ranking order of animals with cholangiomatous cysts (Table I) follows a different pattern to that of hepatocellular tumours and focal proliferations. Groups 1 and 3, given a preliminary dose of CC14, had a higher proportion of animals with cholangiomas and a higher incidence of the lesions in the surviving mice than found in Groups 2 and 4 that had no such preliminary treatment (Grouips 2 and 4 5S99 A. W. POUND AND L. J. MCGUIRE vs Groups 1 and 3: for proportion of animals x2=48, 1 d.f., P<0-025; for incidence of tumours x2 13X9, I d.f., P<0 001). Comparing Groups 2 and 4, repeated doses of CC14 in animals given DEN alone obviously had no effect on the incidence of these growths and, comparing Groups 1 and 3, the increased yield produced by repeated doses of CC14 in animals given DEN after a preliminary injection of CC14 is not statistically significant (x2 ]1, 1 d.f., N.S.).
DISCU,SSION
The increase in the number of hepatocellular tumours produced in animals by a variety of nitrosamines, given when the liver is regenerating actively after a hepatonecrotic dose of CC14, has been reported (Pound, 1978) and is confirmed by the present data with DEN in younger mice. The number of cholangiomatous cysts also increased, and perhaps this may be associated with proliferative processes in the liver. AIn increase in the yield of kidney tumours (Pound et al., 1973; Pound, 1978) , and depression of the activity of microsomal enzymes in regenerating livers following partial surgical or chemical ablation (Barker et al., 1969; Henderson and Kersten, 1971) , in particular of enzymes concerned in metabolism of nitrosamines (Pound and Lawson, 1975) , suggests that metabolic factors may also play a role. Notwithstanding details of the biochemical mechanisms of action, it is evident that some of the liver cells are altered in such a way that some of them subsequently develop into tumours, and that the proportion of dormant tumour cells is increased when the carcinogen is administered to an animal in which the liver is regenerating after partial ablation.
When the dose of DEN was followed 5 weeks later by 7 doses of CC14 at 5-week intervals, the number of hepatocellular tumours that developed was greatly increased. The increase occurred in alnimals that had no preliminary treatment, as wNell as in animals that had a preliminary hepatonecrotic dose of CC14. In animals given both the preliminary treatment and the repeated doses of CC14 after DEN, the increase was greater than if the effects of the preliminary treatment and the subsequent repeated dose in separate experiments were added (172 vs 125, x2,-881, 1 d.f., P<0 05). It is obvious that the number of postulated dormant tumour cells is much larger than eventually appears as tumours, and represents a more or less permanent change. A reasonable interpretation is that the repeated doses of CC14 enhance the probability that they will proliferate to become tumours. The same conclusions follow from a study of the focal proliferations, which appear to be tumours in an early stage of development. Repeated doses of CC14 therefore appear to act in an analogous role to that of a promoting agent in the "two stage" hypothesis for a mechanism of carcinogenesis (Berenblum and Shubik, 1947; Salaman and Roe, 1964) .
The finding that the yield of focal proliferations is greater in the groups treated with multiple injections of CC14 after dosing with DEN than would be expected from the increase in the number of tumours suggests that further groups of dormant cells continue to be brought into a proliferative phase, rather than that this results from acceleration of the rates of growth. The growth kinetics of focal proliferations need to be investigated. If the altered cells divided at a similar rate to normal liver cells and were subject to the same stimulus to proliferate, localized focal accumulations could develop only very slowly. No definitive evidence relating to rates of growth of the lesions was obtained from these experiments.
The hyperplastic response in the liver after 7 doses of CC14 is very great. The dose used produces centrilobular necrosis of about 40%O of the liver in 7-week-old mice, increasing with age to about 7000 in 30-week-old mice. Regenerative hyperplasia restores the liver mass in about 7 days. After 7 doses the liver may be considered to be derived from about 1/200 of the original liver mass, and each cell could have divided 8 or more times. Moreover it would have been derived from the peripheral parts of the liver lobules that escape the hepatonecrotic effect of CC14 and display the least cytological damage by nitrosamines. However, a dose of DEN sharply inhibited DNA synthesis in the regenerating zone and damage to DNA is likely (Pound, unpublished data) . The proliferative response in the bile duct areas is rather less, although significant, and appears to occur at a slower pace. This perhaps is related to the insignificant effect of multiple doses of CC14 on the yield of bile-duct tumours.
The question arises whether the increased hepatocellular tumour yield is related solely to the vigorous hyperplastic response. CC14 itself has a carcinogenic action (Eschenbrenner, 1944) , particularly in some strains of mice, but the tumours develop only after a long time and very many repeated doses. CC14 can therefore only be a weak carcinogen. Neither tumours nor focal proliferations have been produced by the repeated doses of CC14, which are large for a chemical carcinogen, in our mice. On the contrary, the reported weak carcinogenic effect of CC14 may be due to a promoting action with an initiating agent provided by a minor carcinogen in the diet, or even by CC14 itself.
Evidence that the carcinogenic response to DEN in rats, as assessed by the occurrence of focal proliferations and tumours, is increased by three partial hepatectomies at 5-week intervals and starting 5 weeks after dosing with DEN has been reported (Pound and McGuire, 1978) . Problems of interpretation arise in this type of experiment and, although the increase was small, reasons were put forward to regard it as biologically significant. In earlier reports, 3 small partial hepatectomies after a carcinogenic treatment with X-irradiation marginally increased the tumour yield (Haran-Ghera et al., 1962) . A single partial hepatectomy during a course of feeding acetylaminofluorene (Laws, 1959) or di-39 methylaminoazobenzene (Glinos, 1964) accelerated the yield of tumours, but only marginally increased their number. A dose of CC14 after a single carcinogenic dose of X-irradiation (Cole and Nowell, 1965) and up to 9 months after X-irradiation or neutron bombardment (Curtis et al., 1968) marginally increased tumour yields. The single phase of regenerative hyperplasia in these reported experiments is a good deal less vigorous than that produced by our 3 successive partial hepatectomies, when regeneration occurred from about 1/6 of the original liver (Pound and McGuire, 1978) and is very much less than occurs after 7 doses of CC14. If the yield of tumours increased linearly with the number of doses of CC14, a statistically significant increase could be expected after between 2 and 3 doses (implying regeneration from about 1/8 of the original liver mass); this implies a slightly greater hyperplastic response than occurred in the 3 partial hepatectomy experiment. It is therefore possible to assume that the increases caused by partial hepatectomy or by CC14 are not quantitatively inconsistent with each other or with the view that the proliferative response is the significant factor. A rigorously designed comparison of the actions of CC14 and partial hepatectomies in this regard is likely to provide important information.
In the case of promotion in skin carcinogenesis in mice, not all agents that lead to hyperplasia are in fact promoting agents, although the converse is invariably true (Boutwell, 1974) . The two observations are not necessarily in conflict, but the difference may hinge around the cellular mechanisms by which the agent stimulates the hyperplastic response. In the case of CC14, the cytological damage is largely due to an attack on endoplasmic cell membranes (Pound, unpublished) and it is of some interest that this may be a point of attack of the phorbol esters which are active agents in the promoting agent, croton oil (Boutwell, 1974) . Recent data suggest that administration of phorbol to mice dosed with dimethylnitrosamine pro-601 motes tumour formation in the liver and lungs (Armuth and Berenblum, 1972) . It would be of great significance to determine the effect of this chemical on the liver and other tissues.
